Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-22

FDA Approved: ETHOSUXIMIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for ethosuximide from Chartwell RX, LLC, indicating regulatory approval of a change to the approved product under the AN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethosuximide (ethosuximide)

Snippet

SUPPL AP for ETHOSUXIMIDE (ETHOSUXIMIDE)